Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleb Slobodin

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
The Israel Medical Association Journal : IMAJ|August 9, 2017
Pseudoseptic Arthritis with Low Synovial Fluid Glucose in Familial Mediterranean FeverAbid Awisat, Gleb Slobodin, Nizar Jiries, et al.
Case Reports in Infectious Diseases|September 23, 2016
Q Fever Risk in Patients Treated with Chronic Antitumor Necrosis Factor-Alpha TherapyJulianna Hirsch, Anna Astrahan, Majed Odeh, et al.
Rheumatology (Oxford, England)|January 24, 2018
Central retinal vein occlusion in temporal arteritis: red sign or red herring?Lisa Kaly, Gleb Slobodin, Doron Rimar, et al.
Rambam Maimonides Medical Journal|April 28, 2023
Giant Cell Arteritis: State of the Art in Diagnosis, Monitoring, and TreatmentAbid Awisat, Shiri Keret, Amal Silawy, et al.
Arthritis Research & Therapy|June 16, 2012
Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosusZahava Vadasz, Tharwat Haj, Katalin Halasz, et al.
Annals of the Rheumatic Diseases|September 10, 2020
Response to: 'Tofacitinib for the treatment of polyarteritis nodosa: a literature review'. Correspondence on 'Tofacitinib for polyarteritis nodosa: a tailored therapy' by Rimar <i>et al</i>Doron Rimar, Abid Awisat, Lisa Kaly, et al.
Clinical Rheumatology|November 13, 2019
Crowned dens syndrome, yet another rheumatic disease imposterAbid Awisat, Itzhak Rosner, Doron Rimar, et al.
Rheumatology International|April 22, 2015
Semaphorin 3A: an immunoregulator in systemic sclerosisDoron Rimar, Yuval Nov, Itzhak Rosner, et al.
The Israel Medical Association Journal : IMAJ|March 18, 2021
Acute Gout SacroiliitisLisa Kaly, Igor Bilder, Michael Rozenbaum, et al.
Seminars in Arthritis and Rheumatism|September 11, 2016
Autoinflammatory associated vasculitisShira Ginsberg, Itzhak Rosner, Michel Rozenbaum, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
The Israel Medical Association Journal : IMAJ|August 9, 2017
Pseudoseptic Arthritis with Low Synovial Fluid Glucose in Familial Mediterranean FeverAbid Awisat, Gleb Slobodin, Nizar Jiries, et al.
Case Reports in Infectious Diseases|September 23, 2016
Q Fever Risk in Patients Treated with Chronic Antitumor Necrosis Factor-Alpha TherapyJulianna Hirsch, Anna Astrahan, Majed Odeh, et al.
Rheumatology (Oxford, England)|January 24, 2018
Central retinal vein occlusion in temporal arteritis: red sign or red herring?Lisa Kaly, Gleb Slobodin, Doron Rimar, et al.
Rambam Maimonides Medical Journal|April 28, 2023
Giant Cell Arteritis: State of the Art in Diagnosis, Monitoring, and TreatmentAbid Awisat, Shiri Keret, Amal Silawy, et al.
Arthritis Research & Therapy|June 16, 2012
Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosusZahava Vadasz, Tharwat Haj, Katalin Halasz, et al.
Annals of the Rheumatic Diseases|September 10, 2020
Response to: 'Tofacitinib for the treatment of polyarteritis nodosa: a literature review'. Correspondence on 'Tofacitinib for polyarteritis nodosa: a tailored therapy' by Rimar <i>et al</i>Doron Rimar, Abid Awisat, Lisa Kaly, et al.
Clinical Rheumatology|November 13, 2019
Crowned dens syndrome, yet another rheumatic disease imposterAbid Awisat, Itzhak Rosner, Doron Rimar, et al.
Rheumatology International|April 22, 2015
Semaphorin 3A: an immunoregulator in systemic sclerosisDoron Rimar, Yuval Nov, Itzhak Rosner, et al.
The Israel Medical Association Journal : IMAJ|March 18, 2021
Acute Gout SacroiliitisLisa Kaly, Igor Bilder, Michael Rozenbaum, et al.
Seminars in Arthritis and Rheumatism|September 11, 2016
Autoinflammatory associated vasculitisShira Ginsberg, Itzhak Rosner, Michel Rozenbaum, et al.
Pageof 15